Literature DB >> 13886913

Biochemical observations on LSD-25 and Deseril.

W DOEPFNER.   

Abstract

Entities:  

Keywords:  LYSERGIC ACID DIETHYLAMIDE/chemistry

Mesh：

Substances：

Year:  1962        PMID： 13886913     DOI： 10.1007/bf02148217

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  16 in total

1.  [Further contribution on the pharmacology of D-lysergic acid diethylamide; the effect of LSD on circulatory reflexes].

Authors:  H WEIDMANN; A CERLETTI
Journal:  Helv Physiol Pharmacol Acta       Date:  1958

2.  [Pharmacological characterization of deseril, a serotonin antagonist].

Authors:  A FANCHAMPS; W DOEPFNER; H WEIDMANN; A CERLETTI
Journal:  Schweiz Med Wochenschr       Date:  1960-09-10

3.  Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.

Authors:  F SICUTERI
Journal:  Int Arch Allergy Appl Immunol       Date:  1959

4.  Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25).

Authors:  H ISBELL; E J MINER; C R LOGAN
Journal:  Psychopharmacologia       Date:  1959

5.  The distribution and metabolism of lysergic acid diethylamide.

Authors:  J AXELROD; R O BRADY; B WITKOP; E V EVARTS
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

6.  [Central effects of lysergic acid diethylamide; studies on the localization of lysergic acid diethylamide effects].

Authors:  K NEUHOLD; M TAESCHLER; A CERLETTI
Journal:  Helv Physiol Pharmacol Acta       Date:  1957

7.  [The site of action of D-lysergic acid diethylamide and 5-hydroxytryptamine in the melanophore test].

Authors:  B BERDE; A CERLETTI
Journal:  Z Gesamte Exp Med       Date:  1957

8.  Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives.

Authors:  A CERLETTI; E ROTHLIN
Journal:  Nature       Date:  1955-10-22       Impact factor: 49.962

9.  Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine.

Authors:  J H GADDUM
Journal:  J Physiol       Date:  1953-07       Impact factor: 5.182

10.  [Effects of D-Lysergic acid diethylamide and 5-hydroxytryptamine (serotonin) on spinal reflexes in cats].

Authors:  H WEIDMANN; A CERLETTI
Journal:  Helv Physiol Pharmacol Acta       Date:  1957
View more
  8 in total

1.  Failure of antiserotonergic agents to modify levallorphan-induced stereotypy in rats.

Authors:  K C Phillips; S R Wray
Journal:  Psychopharmacologia       Date:  1975

2.  Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide.

Authors:  J P Green; C L Johnson; H Weinstein; S Maayani
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

3.  Evidence of catecholamine mediation in the "aberrant" behaviour induced by lysergic acid diethylamide (LSD) in the rat.

Authors:  A K Dixon
Journal:  Experientia       Date:  1968-07-15

4.  Quantitative determination of ergot alkaloids in biological fluids by radioimmunoassay.

Authors:  T T Kleimola
Journal:  Br J Clin Pharmacol       Date:  1978-09       Impact factor: 4.335

5.  Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion.

Authors:  W B Mendelson; L S Jacobs; J D Reichman; E Othmer; P E Cryer; B Trivedi; W H Daughaday
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Monoamine mediation of the morphine-induced activation of mice.

Authors:  B J Carroll; P T Sharp
Journal:  Br J Pharmacol       Date:  1972-09       Impact factor: 8.739

Review 7.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

8.  Effects of drugs acting on cerebral 5-hydroxytryptamine mechanisms on dopamine-dependent turning behaviour in mice.

Authors:  J A Milson; C J Pycock
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.